We are live on
!
Find out more
CCB
Cutter & Co Brokerage Portfolio holdings
AUM
$423M
1-Year Est. Return
15.02%
This Fund
S&P 500
This Quarter
Est. Return
+11.34%
1 Year Est. Return
+15.02%
3 Year Est. Return
+40.36%
5 Year Est. Return
+171.67%
10 Year Est. Return
+252.8%
AUM
$296M
AUM Growth
+$26.6M
(+9.9%)
Cap. Flow
+$3.96M
Cap. Flow
% of AUM
1.34%
Top 10 Holdings %
Top 10 Hldgs %
41.19%
Holding
240
New
14
Increased
65
Reduced
107
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$10.4M |
| 2 |
Cadre Holdings
CDRE
|
+$2.58M |
| 3 |
Wells Fargo
WFC
|
+$635K |
| 4 |
National Fuel Gas
NFG
|
+$544K |
| 5 |
Linde
LIN
|
+$529K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Genmab
GMAB
|
+$3.77M |
| 2 |
Telephone and Data Systems
TDS
|
+$1.94M |
| 3 |
UGI
UGI
|
+$751K |
| 4 |
International Flavors & Fragrances
IFF
|
+$736K |
| 5 |
Spire
SR
|
+$553K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.27% |
| 2 | Healthcare | 15.41% |
| 3 | Energy | 12.84% |
| 4 | Industrials | 9.9% |
| 5 | Materials | 7.8% |
Similar funds
DFG
RRCM
CAM
SF
EPDL
CWC
CF
MPW
Cutter & Co Brokerage's Q4 2022 Portfolio in Review
As of Q4 2022, Cutter & Co Brokerage held 240 positions worth $296M, up 9.9% from $269M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Cutter & Co Brokerage's Q4 2022 filing shows 14 new, 65 increased, 107 reduced and 23 closed positions. Its largest new stake was Wells Fargo: 14,355 shares worth $593K. The largest sale was Genmab, an estimated $3.77M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Energy.
- Cutter & Co Brokerage's largest Q4 2022 buy was Wells Fargo: 14,355 shares worth $593K.
- Cutter & Co Brokerage added most to Novo Nordisk in Q4 2022, an estimated $10.4M increase.
- Cutter & Co Brokerage's biggest Q4 2022 reduction was International Flavors & Fragrances, cutting an estimated $736K.
- Cutter & Co Brokerage fully exited Genmab in Q4 2022, selling an estimated $3.77M.
- Cutter & Co Brokerage's ten largest holdings make up 41% of its $296M portfolio in Q4 2022.
- Cutter & Co Brokerage opened 14 new positions and closed 23 in Q4 2022.
- Cutter & Co Brokerage's portfolio value rose 9.9% quarter-over-quarter to $296M.
Based on Cutter & Co Brokerage's 13F filing for Q4 2022, filed 3 Feb 2023.